Systems, methods and compositions for optical stimulation of target cells

Compositions and methods for prognosis of ovarian cancer

Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes

siRNA targeting TNFa

THERAPEUTIC AGENT FOR FIBROID LUNG

Methods and materials for treating autoimmune and/or complement mediated diseases and conditions

Antisense formulation

RNA interference for the treatment of heart failure

COMPOSITIONS AND METHODS FOR TREATING CANCER AND MODULATING STRESS GRANULE FORMATION

SIRNA OF HUMAN OSTEOPONTIN

Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor

Compositions and Methods For Diagnosing and Treating Diabetic Micro Vascular Complications

USE OF P27KIP1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE

Compounds suited as nanocarriers for active agents and their use

Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer

Therapy of p53 mutant colon adenocarcinoma, breast cancer and lung cancer

Lipid formulations for nucleic acid delivery

Amphoteric liposomes

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER OR OTHER DISEASES

Method for Treating Hepatitis C Infection

TREATMENT OF RHEUMATOID ARTHRITIS

Compositions and Methods for Modulating Neuron Degeneration and Neuron Guidance

Method for opening tight junctions

Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor

METHODS AND COMPOSITIONS INVOLVING CHITOSAN NANOPARTICLES

Compositions and Methods for the Treatment of Radioresistant Glioma Stem Cells

MAMMALIAN RECEPTORS AS TARGETS FOR ANTIBODY AND ACTIVE VACCINATION THERAPY AGAINST MOLD INFECTIONS

Therapeutic compositions

MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders

Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same

MODULATION OF SRPX2-MEDIATED ANGIOGENESIS

Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase

COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN

METHODS AND COMPOSITIONS FOR REDUCING STEMNESS IN ONCOGENESIS

Method of inhibiting nonsense-mediated mRNA decay

ADJUVANT COMPOSITIONS COMPRISING POLY-IC AND A CATIONIC POLYMER

Induction of thyroid iodide-handling gene expression in human cancers

RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS

Methods of treating eye diseases in diabetic patients

METHODS AND COMPOSITIONS FOR THE INHIBITION OF VIRAL INFECTION BY TARGETING INTRACELLULAR TRAFFICKING

MEANS AND METHODS FOR THE SPECIFIC INHIBITION OF GENES IN CELLS AND TISSUE OF THE CNS AND/OR EYE

Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and BPH

Gene defects and mutant ALK kinase in human solid tumors

COMPOSITIONS FOR DELIVERY OF CARGO SUCH AS DRUGS PROTEINS AND/OR GENETIC MATERIALS

Vaccines and Immunomodulatory Therapies for Tularemia

Lipid formulated dsRNA targeting the PCSK9 gene

Modulation of GLUT4 Gene Promoter activity BY AHNAK

Hepatitis B virus-binding polypeptides and methods of use thereof

Methods and compositions for inhibition of immune responses and autoimmunity

Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression

Peptide-conjugated oligonucleotide therapeutic and method of making and using same

Methods of inhibiting tumor growth using TTK antagonists

siRNA Targeting Survivin

METHOD OF FIXING AND EXPRESSING PHYSIOLOGICALLY ACTIVE SUBSTANCE

Lipid formulation

REDUCING IRF4, DUSP22, OR FLJ43663 POLYPEPTIDE EXPRESSION

siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)

In vivo delivery of double stranded RNA to a target cell

Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias

Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells

AGENTS AND METHODS FOR TREATING RESPIRATORY DISORDERS

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

SUSTAINED-RELEASE MICROSPHERE CONTAINING SHORT CHAIN DEOXYRIBONUCLEIC ACID OR SHORT CHAIN RIBONUCLEIC ACID AND METHOD OF PRODUCING THE SAME

Compositions and methods for treating pruritus

METHOD FOR INHIBITING ANGIOGENESIS OR FOR TREATMENT OF CANCER

RNA INTERFERENCE MEDIATED INHIBITION OF ADENOSINE A1 RECEPTOR (ADORA1) GENE EXPRESSION USING SHORT INTERFERING RNA

Gene defects and mutant ALK kinase in human solid tumors

MicromiRs

COMPOSITIONS COMPRISING STAT3 SIRNA AND METHODS OF USE THEREOF

Oligonucleotide Compositions with Enhanced Efficiency

NEURONAL REGENERATION PROMOTING AGENT

Methods and compositions for selecting siRNA of improved functionality

Class of Gamma Delta T Cells Activators and Use Thereof

Use of IL-23 antagonists for treatment of infection

Modulation of TRPV expression levels

METHODS OF DELIVERING OLIGONUCLEOTIDES TO IMMUNE CELLS

Micro-RNA family that modulates fibrosis and uses thereof

VACCINE

Hox Compositions and Methods

Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method

Combination treatment for the treatment of hepatitis C virus infection

Gene silencing of the brother of the regulator of imprinted sites (BORIS)

Down-regulation of mortalin by siRNA

Inhibitors of MRP4 for the treatment of vascular disorders

COMPOSITIONS COMPRISING STAT5 SIRNA AND METHODS OF USE THEREOF

NANOPARTICLE-MEDIATED TREATMENT FOR INFLAMMATORY DISEASES

PFKFB4 inhibitors and methods of using the same

Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same

LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES

Targeting opposite strand replication intermediates of single-stranded viruses by RNAI

siRNA targeting KRAS

COMPOSITIONS AND METHODS FOR AUGMENTING ACTIVITY OF ONCOLYTIC VIRUSES

Breast Cancer Methods, Medicaments and Agents

Multivalent aptamer complexes

Polyamine derivatives

Method for increasing immunoreactivity

Small interfering DNA (siDNA) oligonucleotides as an antiviral agent against Herpes virus infections

Method of treating skin inflammation

Method to inhibit cell growth using oligonucleotides

MULTIPLEX DICER SUBSTRATE RNA INTERFERENCE MOLECULES HAVING JOINING SEQUENCES

METHODS AND COMPOSITIONS RELATED TO DLK-1 AND THE P38 MAPK PATHWAY IN NERVE REGENERATION

siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)

Compositions and methods for promoting the healing of tissue of multicellular organisms

Marker for the diagnosis of cancer

Therapeutic compositions

Antisense modulation of kinesin-like 1 expression

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

LIPOPEPTIDES FOR DELIVERY OF NUCLEIC ACIDS

METHODS OF ANALYSIS AND DETECTING MOLECULAR DEFECTS IN TRANSCOBALAMIN I DEFICIENCY

Patterns of known and novel small RNAS in human cervical cancer

DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES

RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

METHOD TO INHIBIT CELL GROWTH USING OLIGONUCLEOTIDES

RNAi inhibition of alpha-ENaC expression

RNAi inhibition of alpha-ENaC expression

LIPOSOME AND METHOD FOR PRODUCING LIPOSOME

THERAPEUTIC siRNA MOLECULES FOR REDUCING VEGFR1 EXPRESSION IN VITRO AND IN VIVO

Small activating RNA molecules and methods of use

RNAi inhibition of alpha-ENaC expression

RNAi inhibition of alpha-ENaC expression

Nicked or gapped nucleic acid molecules and uses thereof

Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors

Method and carrier complexes for delivering molecules to cells

SMALL INTERFERING RNA MOLECULES AGAINST RIBONUCLEOTIDE REDUCTASE AND USES THEREOF

C-CBL AND ANTAGONISTS THEREOF FOR THE TREATMENT AND DIAGNOSIS OF CANCER

DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER ASSOCIATED CHROMOSOMAL FEATURES

Human liver regeneration associated protein and the use thereof

Methods and compositions for modulating wound repair

INHIBITORS FOR GROWTH HORMONE AND RELATED HORMONES, AND METHODS OF USE THEREOF

Compositions and methods for modulating ghrelin-mediated conditions

RNAi inhibition of alpha-ENaC expression

Inhibition of Bacterial Protein Production by Polyvalent Oligonucleotide Modified Nanoparticle Conjugates

EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION

Compositions and methods for the diagnosis and therapy of BCL2-associated cancers

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

dsRNA For Treating Viral Infection

Compositions and methods for modulating angiogenesis

Methods and compositions for treating HIV infection

Therapies for cancer using RLIP76

PREVENTIVE/REMEDY FOR CANCER

Extended dicer substrate agents and methods for the specific inhibition of gene expression

EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION

Double-stranded nucleic acid molecule cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer, and bladder cancer

Apoptosis inducer for cancer cell

GNAQ targeted dsRNA compositions and methods for inhibiting expression

Encapsidation of heterologous entities into virus-like particles

Individualized cancer therapy

RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS

siRNA compositions and methods for potently inhibiting viral infection

Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity

Inkjet gene printing

Method for treatment of Huntington's disease through intracranial delivery of sirna

MODULATION OF SID-1 EXPRESSION

siRNA targeting BCL2L1

siRNA targeting nucleoporin 62kDa (Nup62)

RNAi-mediated inhibition of H1F1A for treatment of ocular angiogenesis

Methods for modulating the efficacy of nucleic acid based therapies

Targeting agent for cancer cell or cancer-associated fibroblast

Method of treating diabetes

Modulation of factor 11 expression

DOUBLE-STRANDED OLIGONUCLEOTIDES

Polyvalent RNA-nanoparticle compositions

Cancer marker and therapeutic agent for cancer

Selective Inhibition of Histone Deacetylase 6 for Ocular Neuroprotection or for Treatment or Control of Glaucoma

Lipid formulations for nucleic acid delivery

USE OF TOLL-LIKE RECEPTOR LIGANDS IN TREATING EXCITOTOXIC INJURY, ISCHEMIA AND/OR HYPOXIA

P2Xinhibition of epithelial cancers and papillomas

Environment-responding siRNA carrier using disulfide-cross-linked polymeric micelle

Intracellular DNA receptor

Compositions and methods for inhibiting expression of transthyretin

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

THERAPEUTIC AGENT FOR PERIODONTAL DISEASE AND ALVEOLAR BONE LOSS DUE TO SURGERY

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

Methods of impairing osteoclast differentiation using antibodies that bind siglec-15

Sensitizing Cells for Apoptosis by Selectively Blocking Cytokines

Wound healing

Inhibitor Nucleic Acids

METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME

Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes

Method of treating cancer with an RPN2 gene expression inhibitor

MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE

siRNA targeting spleen tyrosine kinase

Polynucleotides and polypeptide sequences involved in cancer

Modified L-Nucleic Acid

Isoform of bruton's tyrosine kinase (BTK) protein

Systems and method for configuring display resolution in a terminal server environment

Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells

siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)

Polyethylene glycol derivative

Chemically modified oligonucleotides

Treatment of neurodegenerative disease through intracranial delivery of SIRNA

Prompt nucleic acid delivery carrier composition

Coated lipid complexes and their use

Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis

PEPTIDES USEFUL AS CELL-PENETRATING PEPTIDES

METHODS AND COMPOSITIONS FOR INHIBITION OF AXONAL DEGENERATION BY MODULATION OF THE DLK/JNK PATHWAY

CATIONIC LIPIDS AND USES THEREOF

Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors

Carrier nanoparticles and related compositions, methods and systems

Biodegradable poly(beta-amino esters) and uses thereof

COMPOSITIONS COMPRISING A SIRNA AND LIPIDIC 4,5-DISUBSTITUTED 2-DEOXYSTREPTAMINE RING AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF

RNAi inhibition of CTGF for treatment of ocular disorders

Methods and compositons featuring TGF-beta antagonists for the treatment of marfan syndrome and associated disorders

siRNA targeting survivin

Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells

SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)

Antisense RNA for treating cancer and inhibition of metastasis and vectors for antisense sequestration

Compositions and use of EPAS1 inhibitors

siRNA targeting myeloid cell Leukemia sequence 1

Polymer conjugates of Box-A of HMGB1 and Box-A variants of HMGB1

Methods of identifying and treating poor-prognosis cancers

RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

Cancer therapy using Bcl-X-specific siNA

siRNA targeting TNFα

Treatment of a disease or a condition associated with aberrant gene hypomethylation by a method involving tailored epigenomic modification

Methods and Compositions Related to TR4

siRNA targeting KRAS

Galactose derivative, drug carrier and medicinal composition

Compositions for the prevention and treatment of neuroinjury and methods of use thereof

siRNA targeting transducin (beta)-like 3 (TBL3)

Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same

Ligand-conjugated monomers

INDUCTION OF APOPTOSIS IN TOLL-LIKE RECEPTOR EXPRESSING TUMOR CELLS

RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)

Methods for treating atrial or ventricular arrhythmias

siRNA targeting inner centromere protein antigens (INCENP)

USP47 inhibtors and methods to induce apoptosis

Modified siRNA molecules and uses thereof

Composition comprising an antisense sequence implicated in the regulation of angiogenesis

INHIBITORS OF T-DARPP FOR USE IN COMBINATION ANTI-CANCER THERAPIES

Means and methods of using a NADPH oxidase inhibitor for the treatment of hearing loss and phantom hearing

METHODS OF DIAGNOSING ALZHEIMER'S DISEASE AND MARKERS IDENTIFIED BY SET ASSOCIATION

Methods of diagnosing alzheimer's disease and markers identified by set association

RNA INTERFERENCE MEDIATED INHIBITION OF B-CELL CLL/LYMPHOMA-2 (BCL2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

Targeting Lipids

RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNAi modulation of RSV and therapeutic uses thereof

Multitargeting Interfering RNAs And Methods Of Their Use And Design

Carbohydrate conjugates as delivery agents for oligonucleotides

METHODS AND COMPOSITIONS FOR PREVENTION OR TREATMENT OF RSV INFECTION

RNAi modulation of RSV and therapeutic uses thereof

Prostaglandin transporter inhibitors

Compositions and methods for treatment of prostate and other cancers

Method of cancer treatment using siRNA silencing

Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary Hypertension

LIPOSOME ENCAPSULATED POLY-ICLC METHOD TO PROPHYLACTICALLY TREAT AN AVIAN INFLUENZA VIRAL INFECTION

METHOD TO INHIBIT CELL GROWTH USING OLIGONUCLEOTIDES

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

siRNA targeting cyclin-dependent kinase 4 (CDK4)

vWF aptamer formulations and methods for use

Glycoconjugates of RNA interference agents

Method for inhibiting onset of or treating pollen allergy

Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology

RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA)

Multitargeting interfering RNAs having two active strands and methods for their design and use

Interfering RNA molecules

METHOD OF PREVENTION AND ALLEVIATION OF TOXICITY BY MODULATION OF IRF3

Methods and compositions for treating cellular proliferative diseases

Methods and compositions involving miRNA and miRNA inhibitor molecules

Wound healing

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

siRNA targeting myeloid cell leukemia sequence 1

siRNA targeting tumor necrosis factor receptor superfamily member 1A

RNAi inhibition of alpha-ENaC expression

Gene defects and mutant ALK kinase in human solid tumors

Method of manufacturing an article of footwear with a fluid-filled chamber

SiRNA targeting KRAS

MicroRNAs

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (SINA)

RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/ REL-A GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF ANGIOPOIETIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

TARGETING OPPOSITE STRAND REPLICATION INTERMEDIATES OF SINGLE-STRANDED VIRUSES BY RNAI

LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY

Medicament and method for treating recurrent spontaneous abortion

PROSTATE CARCINOGENESIS PREDICTOR

Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen

siRNA targeting nucleoporin 62kDa (Nup62)

Compositions for conferring tolerance to viral disease in social insects, and the use thereof

Targeting ABCB5 for cancer therapy

Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases

Detection and treatment of autoimmune disorders

PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease

siRNA targeting transducin (beta)-like 3 (TBL3)

In-situ cancer autovaccination with intratumoral stabilized dsRNA viral mimic

Uniform field magnetization and targeting of therapeutic formulations

siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)

Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agents

siRNA targeting inner centromere protein antigens (INCENP)

METHOD FOR PRODUCING A NUCLEIC-ACID-CONTAINING COMPLEX PREPARATION

Method for ProNGF assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of ProNGF

Compositions and methods of treating cancer

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation

Methods and Compositions for Reducing Stemness in Oncogenesis